Factors associated with antibiotic misuse in outpatient treatment for upper respiratory tract infections

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 7, 2015, Pages 3848-3852

  Schroeck, Jennifer L ^a   Ruh, Christine A ^a   Sellick, John A ^a,b   Ott, Michael C ^c   Mattappallil, Arun ^a,d   Mergenhagen, Kari A ^a  

^a VA WESTERN NEW YORK HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c ERIE COUNTY MEDICAL CENTER   (United States)

^d East Orange VA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTIVIRUS AGENT; AZITHROMYCIN; CEPHALOSPORIN; CLINDAMYCIN; MACROLIDE; MOXIFLOXACIN; PENICILLIN DERIVATIVE; QUINOLONE DERIVATIVE; SULFANILAMIDE; TETRACYCLINE; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COUGHING; DRUG MISUSE; FEMALE; FEVER; HOSPITAL ADMISSION; HOSPITAL READMISSION; HUMAN; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTPATIENT CARE; PATIENT COMPLIANCE; PENICILLIN ALLERGY; PHARYNGITIS; PRESCRIPTION; PRIORITY JOURNAL; SINUSITIS; UPPER RESPIRATORY TRACT INFECTION; VETERAN; AMBULATORY CARE; CLINICAL PRACTICE; DRUG UTILIZATION; INAPPROPRIATE PRESCRIBING; MIDDLE AGED; MULTIVARIATE ANALYSIS; OUTPATIENT; PUBLIC HEALTH SERVICE; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; UNITED STATES;

AMBULATORY CARE; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); DRUG UTILIZATION; FEMALE; FLUOROQUINOLONES; HUMANS; INAPPROPRIATE PRESCRIBING; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OUTPATIENTS; PRACTICE PATTERNS, PHYSICIANS'; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84935910128     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00652-15     Document Type: Article

References (20)

1. Centers for Disease Control and Prevention. 2013. Get Smart programs & observances. Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/getsmart/. Accessed 29 October 2014.
2. Institute of Medicine. 2003. Microbial threats to health: emergence, detection, and response. The National Academies Press, Washington, DC.
3. Gonzales R, Malone DC, Maselli JH, Sande MA. 2001. Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis 33:757-762. http://dx.doi.org/10.1086/322627.
4. Centers for Disease Control and Prevention (CDC). 2011. Office-related antibiotic prescribing for persons aged ≤14 years-United States, 1993-1994 to 2007-2008. MMWR Morb Mortal Wkly Rep 60:1153-1156.
5. Logan JL, Yang J, Forrest G. 2012. Outpatient antibiotic prescribing in a low-risk veteran population with acute respiratory symptoms. Hosp Pract 40:75-80. http://dx.doi.org/10.3810/hp.2012.02.948.
6. Gonzales R, Bartlett JG, Besser RE, Hickner JM, Hoffman JR, Sande MA, American Academy of Family Physicians, Infectious Diseases Society of America, Centers for Disease Control, American College of Physicians-American Society of Internal Medicine. 2001. Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults: background. Ann Intern Med 134:490-494. http://dx.doi.org/10.7326/0003-4819-134-6-200103200-00015.
7. Hicks LA, Taylor TH, Jr, Hunkler RJ. 2013. U.S. outpatient antibiotic prescribing, 2010. N Engl J Med 368:1461-1462. http://dx.doi.org/10.1056/NEJMc1212055.
8. Centers for Disease Control and Prevention. 2009. Nonspecific upper respiratory tract infection: physician information sheet (adults). Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov /getsmart/campaign-materials/info-sheets/adult-nurti.html. Accessed 29 October 2014.
9. Centers for Disease Control and Prevention. 2013. Bronchitis (chest cold). Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/getsmart/antibiotic-use/uri/bronchitis.html. Accessed 29 October 2014.
10. Centers for Disease Control and Prevention. 2009. Acute bacterial rhinosinusitis: physician information sheet (adults). Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/getsmart/campaign-materials /info-sheets/adult-acute-bact-rhino.html. Accessed 29 October 2014.
11. Centers for Disease Control and Prevention. 2013. Sore throat. Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/getsmart/antibiotic-use/URI/sore-throat.html. Accessed 29 October 2014.
12. Chow AW, Benninger MS, Brook I, Brozek JL, Goldstein EJ, Hicks LA, Pankey GA, Seleznick M, Volturo G, Wald ER, File TM, Jr, Infectious Diseases Society of America. 2012. IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. Clin Infect Dis 54: e72-e112. http://dx.doi.org/10.1093/cid/cis370.
13. Pichichero ME. 2002. Dynamics of antibiotic prescribing for children. JAMA 287:3133-3135. http://dx.doi.org/10.1001/jama.287.23.3133.
14. Huttner B, Goossens H, Verheij T, Harbarth S, CHAMP consortium. 2010. Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries. Lancet Infect Dis 10:17-31. http://dx.doi.org/10.1016/S1473-3099(09)70305-6.
15. Albrich WC, Monnet DL, Harbarth S. 2004. Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes. Emerg Infect Dis 10:514-517. http://dx.doi.org/10.3201/eid1003.030252.
16. Hicks LA, Chien YW, Taylor TH, Jr, Haber M, Klugman KP. 2011. Outpatient antibiotic prescribing and nonsusceptible Streptococcus pneumoniae in the United States, 1996-2003. Clin Infect Dis 53:631-639. http://dx.doi.org/10.1093/cid/cir443.
17. Aspinall SL, Metlay JP, Maselli JH, Gonzales R. 2007. Impact of hospital formularies on fluoroquinolone prescribing in emergency departments. Am J Manag Care 13:241-248.
18. Muto CA, Pokrywka M, Shutt K, Mendelsohn AB, Nouri K, Posey K, Roberts T, Croyle K, Krystofiak S, Patel-Brown S, Pasculle AW, Paterson DL, Saul M, Harrison LH. 2005. A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol 26:273-280. http://dx.doi.org/10.1086/502539.
19. Neuhauser MM, Weinstein RA, Rydman R, Danziger LH, Karam G, Quinn JP. 2003. Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. JAMA 289: 885-888. http://dx.doi.org/10.1001/jama.289.7.885.
20. Sanchez GV, Roberts RM, Albert AP, Johnson DD, Hicks LA. 2014. Effects of knowledge, attitudes, and practices of primary care providers on antibiotic selection, United States. Emerg Infect Dis 20:2041-2047. http://dx.doi.org/10.3201/eid2012.140331.